<?xml version="1.0" encoding="ISO-8859-1"?>
<rss version="2.0">
<channel>
<title>Entocort (Budesonide)</title>
<link>http://genericentocort.infohttp://genericentocort.info/</link>
<description>Entocort (Budesonide)</description>
<item>
<title>entocort pills News - Entocort for colitis</title>
<link>http://genericentocort.infohttp://genericentocort.info/entocort-pills/Entocort-for-colitis/</link>
<description><![CDATA[<p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.pharmatimes.com%2FUKNews%2Farticle.aspx%3Fid%3D17478&amp;usg=AFQjCNGCIxy8eKj8MkZXTeUx02S9EwqrdQ">AstraZeneca buys out Merck&#39;s rights to a number of drugs</a><br />Pharma Times<br /> drugmaker is exercising an option which will see Merck relinquish the rights to Entocort (budesonide) for Crohn&#39;s disease and ulcerative colitis, <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=deshY0BaVG1kvVM">and more&nbsp;&raquo;</a></p><p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fseekingalpha.com%2Farticle%2F191834-santarus-inc-q4-2009-earnings-call-transcript&amp;usg=AFQjCNH0mvL06P35yEGEPSsLBR-zEZHITA">Q4 2009 Earnings Call Transcript</a><br />Seeking Alpha (blog)<br />In the US study, the reference drug is Asacol tablets, and in the European study, it is Entocort EC capsules. The primary endpoint of the Phase III clinical <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=dx7uCqsM3r7MpFM">and more&nbsp;&raquo;</a></p>]]></description>
<category>entocort pills</category>
</item>
<item>
<title>Entocort  online News - Entocort how long</title>
<link>http://genericentocort.infohttp://genericentocort.info/Entocort--online/Entocort-how-long/</link>
<description><![CDATA[<p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.reuters.com%2Farticle%2FidUSLDE6201BY20100301%3Ftype%3DmarketsNews&amp;usg=AFQjCNGA8IDrOdoPAt8mScFBu2B7w-BKXQ">Astra unties part of US Merck deal for $647 mln</a><br />Reuters<br />Products covered by the option include Entocort for Crohn&#39;s disease, the heart drugs Atacand and Plendil, and certain products still in development, <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=djnZunBBK7eQdxM">and more&nbsp;&raquo;</a></p><p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fseekingalpha.com%2Farticle%2F191834-santarus-inc-q4-2009-earnings-call-transcript&amp;usg=AFQjCNH0mvL06P35yEGEPSsLBR-zEZHITA">Q4 2009 Earnings Call Transcript</a><br />Seeking Alpha (blog)<br />In the US study, the reference drug is Asacol tablets, and in the European study, it is Entocort EC capsules. The primary endpoint of the Phase III clinical <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=dx7uCqsM3r7MpFM">and more&nbsp;&raquo;</a></p><p><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.bioon.com%2Findustry%2Fenterprisenews%2F434466.shtml&amp;usg=AFQjCNHGRMI3o-bBw0P4tDJsK_GDZvUxwA"><img src="http://nt3.ggpht.com/news/tbn/P-MF6XCryxGBMM/6.jpg" alt="" border="1" width="80" height="80" /><br />生物谷</a><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.bioon.com%2Findustry%2Fenterprisenews%2F434466.shtml&amp;usg=AFQjCNHGRMI3o-bBw0P4tDJsK_GDZvUxwA">阿斯利康（AstraZeneca）支付6.47亿购入默克（Merck）合作产品的股权</a><br />生物谷<br />默克表示，接获AstraZeneca(AZN)通知，指出AstraZeneca执行其选择权，今年将购入默克持有的非质子帮浦抑制剂产品股权，这些产品包括Atacand,LEXxel,Plendil,Entocort, <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;hl=zh-CN&amp;ncl=dOSr007kEoOLUnM"></a></p>]]></description>
<category>Entocort  online</category>
</item>
<item>
<title>entocort News - Generic for entocort</title>
<link>http://genericentocort.infohttp://genericentocort.info/entocort/Generic-for-entocort/</link>
<description><![CDATA[<p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fonline.wsj.com%2Farticle%2FBT-CO-20100301-704863.html%3Fmod%3DWSJ_Deals_LEFTLatestHeadlines&amp;usg=AFQjCNGN2vURedLmI2tM4o7oOebWWLMNow">AstraZeneca Will Excercise First Option In Merck JV</a><br />Wall Street Journal<br />LN), said Monday it has notified Merck (MRK) that it will exercise the first option to buy Entocort, Atacand and Plendil, and certain products still in <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=dATQI8rBOhI49hM">and more&nbsp;&raquo;</a></p><p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fseekingalpha.com%2Farticle%2F191834-santarus-inc-q4-2009-earnings-call-transcript&amp;usg=AFQjCNH0mvL06P35yEGEPSsLBR-zEZHITA">Q4 2009 Earnings Call Transcript</a><br />Seeking Alpha (blog)<br />In the US study, the reference drug is Asacol tablets, and in the European study, it is Entocort EC capsules. The primary endpoint of the Phase III clinical <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=dx7uCqsM3r7MpFM">and more&nbsp;&raquo;</a></p>]]></description>
<category>entocort</category>
</item>
<item>
<title>entocort pills News - Entocort ec generic</title>
<link>http://genericentocort.infohttp://genericentocort.info/entocort-pills/Entocort-ec-generic/</link>
<description><![CDATA[<p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fonline.wsj.com%2Farticle%2FBT-CO-20100301-704863.html%3Fmod%3DWSJ_Deals_LEFTLatestHeadlines&amp;usg=AFQjCNGN2vURedLmI2tM4o7oOebWWLMNow">AstraZeneca Will Excercise First Option In Merck JV</a><br />Wall Street Journal<br />LN), said Monday it has notified Merck (MRK) that it will exercise the first option to buy Entocort, Atacand and Plendil, and certain products still in <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=dATQI8rBOhI49hM">and more&nbsp;&raquo;</a></p><p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fseekingalpha.com%2Farticle%2F191834-santarus-inc-q4-2009-earnings-call-transcript&amp;usg=AFQjCNH0mvL06P35yEGEPSsLBR-zEZHITA">Q4 2009 Earnings Call Transcript</a><br />Seeking Alpha (blog)<br />In the US study, the reference drug is Asacol tablets, and in the European study, it is Entocort EC capsules. The primary endpoint of the Phase III clinical <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=dx7uCqsM3r7MpFM">and more&nbsp;&raquo;</a></p>]]></description>
<category>entocort pills</category>
</item>
<item>
<title>entocort pills News - Entocort budesonide</title>
<link>http://genericentocort.infohttp://genericentocort.info/entocort-pills/Entocort-budesonide/</link>
<description><![CDATA[<p><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.nj.com%2Fbusiness%2Findex.ssf%2F2010%2F03%2Fastrazeneca_to_pay_merck_647_m.html&amp;usg=AFQjCNHPsjDPKb50qrEONB7eM3Jjh5gQBg"><img src="http://nt0.ggpht.com/news/tbn/HEfwc-FDOug3HM/6.jpg" alt="" border="1" width="80" height="80" /><br />The Star-Ledger - NJ.com</a><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.pharmatimes.com%2FUKNews%2Farticle.aspx%3Fid%3D17478&amp;usg=AFQjCNGCIxy8eKj8MkZXTeUx02S9EwqrdQ">AstraZeneca buys out Merck&#39;s rights to a number of drugs</a><br />Pharma Times<br />The Anglo-Swedish drugmaker is exercising an option which will see Merck relinquish the rights to Entocort (budesonide) for Crohn&#39;s disease and ulcerative <br /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fdrugstorenews.com%2Fstory.aspx%3Fid%3D132223%26menuid%3D787&amp;usg=AFQjCNEc4DM9WMNlvR5CobEiWO1KnPF0tw">AstraZeneca to buy drugs it developed with Merck</a>Drug Store News (blog)<br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=deshY0BaVG1kvVMOeQEkh9nupWYBM">all 60 news articles&nbsp;&raquo;</a></p><p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fseekingalpha.com%2Farticle%2F191834-santarus-inc-q4-2009-earnings-call-transcript&amp;usg=AFQjCNH0mvL06P35yEGEPSsLBR-zEZHITA">Q4 2009 Earnings Call Transcript</a><br />Seeking Alpha (blog)<br />Turning to our clinical programs, enrollment has been completed in the European Phase III clinical study for budesonide MMX for induction of remission of <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=dx7uCqsM3r7MpFM">and more&nbsp;&raquo;</a></p>]]></description>
<category>entocort pills</category>
</item>
<item>
<title>entocort pills News - Entocort order online</title>
<link>http://genericentocort.infohttp://genericentocort.info/entocort-pills/Entocort-order-online/</link>
<description><![CDATA[<p><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.nj.com%2Fbusiness%2Findex.ssf%2F2010%2F03%2Fastrazeneca_to_pay_merck_647_m.html&amp;usg=AFQjCNHPsjDPKb50qrEONB7eM3Jjh5gQBg"><img src="http://nt0.ggpht.com/news/tbn/HEfwc-FDOug3HM/6.jpg" alt="" border="1" width="80" height="80" /><br />The Star-Ledger - NJ.com</a><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.nj.com%2Fbusiness%2Findex.ssf%2F2010%2F03%2Fastrazeneca_to_pay_merck_647_m.html&amp;usg=AFQjCNHPsjDPKb50qrEONB7eM3Jjh5gQBg">AstraZeneca to pay Merck $647 million for rights to drugs</a><br />The Star-Ledger - NJ.com<br /> AstraZeneca will excercise an option to buy the former&#39;s interest in non-proton pump inhibitor products such as Atacand, Lexxel, Plendil and Entocort, <br /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fdrugstorenews.com%2Fstory.aspx%3Fid%3D132223%26menuid%3D787&amp;usg=AFQjCNEc4DM9WMNlvR5CobEiWO1KnPF0tw">AstraZeneca to buy drugs it developed with Merck</a>Drug Store News (blog)<br /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.fiercepharma.com%2Fstory%2FAZ-pay-647m-merck-rights%2F2010-03-01&amp;usg=AFQjCNGwHPUOYwFWAqFAqSruUjYFf0vfTg">AZ to pay $647M for Merck rights</a>FiercePharma<br /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.pharmatimes.com%2FUKNews%2Farticle.aspx%3Fid%3D17478&amp;usg=AFQjCNGCIxy8eKj8MkZXTeUx02S9EwqrdQ">AstraZeneca buys out Merck&#39;s rights to a number of drugs</a>Pharma Times<br /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.businessweek.com%2Fap%2Ffinancialnews%2FD9E5RK780.htm&amp;usg=AFQjCNHnZpQ7Ejoc3B8Pal7FdSGful1Z2g">BusinessWeek</a>&nbsp;-<a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.rttnews.com%2FArticleView.aspx%3FId%3D1225424%26SMap%3D1&amp;usg=AFQjCNHK5dzNGF6JOlMh0_Q8eAcjj34m-w">RTT News</a>&nbsp;-<a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.nasdaq.com%2Faspx%2Fstock-market-news-story.aspx%3Fstoryid%3D201003010728dowjonesdjonline000358%26title%3Dastrazeneca-will-excercise-first-option-in-merck-jv&amp;usg=AFQjCNE0hFYswb92O5EaVZLXngUxuroukQ">NASDAQ</a><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=dku30P8hx1HR6VMeshY0BaVG1kvVM">all 60 news articles&nbsp;&raquo;</a></p><p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.cnbc.com%2Fid%2F35637374&amp;usg=AFQjCNG7sEw6Q6dnbJTBK-Inq10WVENIbg">US stocks end higher, led by technology</a><br />CNBC<br />In news that does involve Dow component Merck, AstraZeneca said it plays to exercise an option to buy rights to Entocort, Atacand and Plendil and several <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=dkXKbW1_VNudjmM">and more&nbsp;&raquo;</a></p><p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.pharmabiz.com%2Farticle%2Fdetnews.asp%3Farticleid%3D54340%26sectionid%3D&amp;usg=AFQjCNGhvI8pUb8OwiA76z81HAZK0isr9w">AstraZeneca to buy Merck&#39;s interest in non-proton pump inhibitor products</a><br />pharmabiz.com<br />Those products are Atacand, Lexxel, Plendil and Entocort plus certain products currently in clinical development. In April, Merck will receive a payment of <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=dsXw8WhnqXqLK7M"></a></p><p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.cnbc.com%2Fid%2F35647142&amp;usg=AFQjCNFCBJxkH7g9dofpEa3qL3i4mkwUAw">Stocks Push Higher, Led by by Technology</a><br />CNBC<br />AstraZeneca said it plays to exercise an option to buy rights to Entocort, Atacand and Plendil and several other products under development. <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=dDvGLHM5kxQyOBM"></a></p>]]></description>
<category>entocort pills</category>
</item>
</channel>
</rss>